cust.co / NRR Benchmark / Healthcare SaaS

Healthcare SaaS NRR Benchmark

Net Revenue Retention across 8 healthcare saas companies in the cust.co dataset, aggregated across all funding stages and ACV bands.

Latest median NRR · FY-2025
104%
down -4.5pp QoQ · down -8pp YoY
8 companies
55 verified disclosures
P25–P75: 98% – 121%

NRR over time - vertical-wide

80%106%133%159%185% 2020-Q32021-Q32022-Q42023-Q42024-Q22025-Q2FY-2021FY-2024FY-2025 Median NRR (vertical) Shaded area: 25th–75th percentile range across contributing companies 2020-Q3 - 167% (DOCS) 2020-Q4 - 173% (DOCS) 2021-Q2 - 139% (DOCS) 2021-Q3 - 139% (DOCS) 2021-Q4 - 128% (DOCS) 2022-Q1 - 133% (DOCS) 2022-Q4 - 104% (NRC) 2022-Q2 - 153% (DOCS) 2023-Q3 - 121% (OPRX, DOCS) 2023-Q4 - 101% (NRC, OPRX, GH, EVCM, DH) 2023-Q2 - 117% (DOCS) 2024-Q1 - 92% (DH, EVCM) 2024-Q2 - 114% (DOCS, OPRX, EVCM) 2024-Q3 - 114% (EVCM, OPRX, DOCS) 2024-Q4 - 102% (OPRX, DOCS, EVCM, NRC, DH, HCAT) 2025-Q2 - 109% (DOCS, OPRX, EVCM, PRVA) 2025-Q3 - 108% (DOCS, EVCM, OPRX, HCAT) 2025-Q4 - 101% (DOCS, OPRX, EVCM, HCAT, NRC) FY-2021 - 117% (DOCS) FY-2022 - 112% (DOCS, NRC) FY-2023 - 109% (GH, NRC) FY-2024 - 121% (OPRX) 2025-Q1 - 109% (OPRX, EVCM, DOCS, HCAT) FY-2025 - 104% (OPRX, HCAT) P25–P75 spread

Each point is the median across all healthcare saas companies that disclosed in that period. Shaded area = 25th-75th percentile range.

Cells in this vertical

2 (stage × ACV band) cells with verified data. Click a row to drill into peer-cell distribution + top performers.

StageACV bandLatest medianHistorySample
Public $25K-$100K ACV 112% 3 co · 23 obs View →
Public $100K-$500K ACV 108.5% 3 co · 18 obs View →

Companies in this vertical

8 verified companies. Showing top 8 alphabetically.

How does your NRR compare to healthcare saas peers?

Results in 30 seconds. We email a shareable percentile badge.